Pharmazell (India) Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 10.92 Cr
as on 27-06-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.58 Cr
as on 27-06-2024
- Revenue -10.78%
(FY 2022)
- Profit 39.87%
(FY 2022)
- Ebitda -19.14%
(FY 2022)
- Net Worth 5.51%
(FY 2022)
- Total Assets 8.09%
(FY 2022)
About Pharmazell (India)
The Corporate was formerly known as Diamalt Pharmorganica Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 10.92 Cr.
The company has closed loans amounting to ₹15.58 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pharmazell (India) Private Limited India is Durai Kumar as COMPANY SECRETARY. Appa Suryadevara, Sukumar Mani, Anant Barbadikar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24294TN1993PTC025852
- Company No.
025852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharmazell (India) Private Limited offer?
Pharmazell (India) Private Limited offers a wide range of products and services, including Product Development Research, Pharmaceutical Research Services, R&D Consulting Services, Custom Synthesis Service, Fertilizer, Amino Acids, Biogas Plant, Pilot Scale Fermentor.
Who are the key members and board of directors at Pharmazell (India)?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anant Barbadikar  | Managing Director | 19-Feb-2010 | Current |
| Durai Kumar | Company Secretary | 05-May-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Appa Suryadevara | Director | 04-May-2024 | Current |
| Sukumar Mani | Director | 04-May-2024 | Current |
| Nagarajan Karthik | Director | 04-May-2024 | Current |
| Manoharan | Whole-Time Director | 01-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Pharmazell (India).
Pharmazell (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.78% decrease. The company also saw a substantial improvement in profitability, with a 39.87% increase in profit. The company's net worth moved up by a moderate rise of 5.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmazell (India)?
In 2022, Pharmazell (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2016 | ₹15.58 Cr | Satisfied |
How Many Employees Work at Pharmazell (India)?
Pharmazell (India) has a workforce of 536 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmazell (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmazell (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
